These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3077021)

  • 1. The chemotherapy of rodent malaria.XLIII. Indolo (3,2-c) quinoline-N-oxides.
    Peters W; Robinson BL
    Ann Trop Med Parasitol; 1988 Oct; 82(5):423-7. PubMed ID: 3077021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemotherapy of rodent malaria. XLIV. Studies on the mode of action of CM 6606, an indolo (3,2-c) quinoline N-oxide.
    Peters W; Robinson BL; Mutambu SL; Warhurst DC; Ellis DS; Tovey DG
    Ann Trop Med Parasitol; 1989 Feb; 83(1):1-10. PubMed ID: 2688575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605.
    Peters W; Robinson BL; Milhous WK
    Ann Trop Med Parasitol; 1993 Dec; 87(6):547-52. PubMed ID: 8122915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemotherapy of rodent malaria, XXVII. Studies on mefloquine (WR 142,490).
    Peters W; Howells RE; Portus J; Robinson BL; Thomas S; Warhurst DC
    Ann Trop Med Parasitol; 1977 Dec; 71(4):407-18. PubMed ID: 339856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally Effective Aminoalkyl 10H-Indolo[3,2-b]quinoline-11-carboxamide Kills the Malaria Parasite by Inhibiting Host Hemoglobin Uptake.
    Mudududdla R; Mohanakrishnan D; Bharate SS; Vishwakarma RA; Sahal D; Bharate SB
    ChemMedChem; 2018 Dec; 13(23):2581-2598. PubMed ID: 30358112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic studies with mefloquine and selection of a mefloquine resistant strain of Plasmodium berghei.
    Kazim M; Puri SK; Dutta GP
    Indian J Med Res; 1979 Dec; 70 Suppl():95-102. PubMed ID: 121298
    [No Abstract]   [Full Text] [Related]  

  • 7. 8-Quinolinamines conjugated with amino acids are exhibiting potent blood-schizontocidal antimalarial activities.
    Vangapandu S; Sachdeva S; Jain M; Singh S; Singh PP; Kaul CL; Jain R
    Bioorg Med Chem; 2004 Jan; 12(1):239-47. PubMed ID: 14697789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemotherapy of rodent malaria. XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 2: Structure-activity studies on cis-fused cyclopenteno-1,2,4-trioxanes (fenozans) against drug-sensitive and drug-resistant lines of Plasmodium berghei and P. yoelii ssp. NS in vivo.
    Peters W; Robinson BL; Rossier JC; Misra D; Jefford CW; Rossiter JC
    Ann Trop Med Parasitol; 1993 Feb; 87(1):9-16. PubMed ID: 8346994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial activity of floxacrine (HOE 991) II: Studies on causal prophylactic and blood schizontocidal action of floxacrine and related dihydroacridinediones against Plasmodium yoelii and P. berghei.
    Raether W; Fink E
    Ann Trop Med Parasitol; 1982 Oct; 76(5):507-16. PubMed ID: 6760821
    [No Abstract]   [Full Text] [Related]  

  • 10. The chemotherapy of rodent malaria, XXVIII. The development of resistance to mefloquine (WR 142,490).
    Peters W; Portus J; Robinson BL
    Ann Trop Med Parasitol; 1977 Dec; 71(4):419-27. PubMed ID: 339857
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of causal prophylactic activity in Plasmodium berghei yoelii and its value for the development of new antimalarial drugs.
    Fink E
    Bull World Health Organ; 1974; 50(3-4):213-22. PubMed ID: 4155355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'.
    Peters W; Robinson BL
    Ann Trop Med Parasitol; 1984 Oct; 78(5):459-66. PubMed ID: 6395814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity.
    Jain M; Vangapandu S; Sachdeva S; Singh S; Singh PP; Jena GB; Tikoo K; Ramarao P; Kaul CL; Jain R
    J Med Chem; 2004 Jan; 47(2):285-7. PubMed ID: 14711300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemotherapy of rodent malaria, XXIII Causal prophylaxis, part II: Practical experience with Plasmodium yoelii nigeriensis in drug screening.
    Peters W; Davies EE; Robinson BL
    Ann Trop Med Parasitol; 1975 Sep; 69(3):311-28. PubMed ID: 1098590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent studies on antimalarial efficacy of piperaquine and hydroxypiperaquine.
    Chen L
    Chin Med J (Engl); 1991 Feb; 104(2):161-3. PubMed ID: 1874015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and blood-schizontocidal antimalarial activities of 2-substituted/2,5-disubstituted-8-quinolinamines and some of their amino acid conjugates.
    Jain M; Vangapandu S; Sachdeva S; Jain R
    Bioorg Med Chem; 2004 Mar; 12(5):1003-10. PubMed ID: 14980613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemotherapy of rodent malaria, XXXVIII. Studies on the activity of three new antimalarials (WR 194,965, WR 228,258 and WR 225,448) against rodent and human malaria parasites (Plasmodium berghei and P. falciparum).
    Peters W; Irare SG; Ellis DS; Warhurst DC; Robinson BL
    Ann Trop Med Parasitol; 1984 Dec; 78(6):567-79. PubMed ID: 6398032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemotherapy of rodent malaria. LIV. Combinations of 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane, with other drugs against drug-sensitive and drug-resistant parasites.
    Fleck SL; Robinson BL; Peters W
    Ann Trop Med Parasitol; 1997 Jan; 91(1):33-9. PubMed ID: 9093427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity.
    Peters W
    Ann Trop Med Parasitol; 1975 Jun; 69(2):155-71. PubMed ID: 1098584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.